Recently, the US FDA announced that it has approved the listing of the calcitonin gene-related pepti

Novartis recently announced topline results from its pivotal global Phase III LUSTER-11and LUSTER-22

November 22, 2019, Roche announces data from positive studies of the IMbrave 150 phase III clinical

Flumatinib is a tyrosine kinase inhibitor and it’s a second-generation TK inhibitor drug against Bcr

Recently, Lilly announced that the US FDA approved the company's development of Reyvow (lasmidit

On August 14th, the FDA approved TB Alliance new fluorine-containing anti-tuberculosis drug Pretoman

To all departments and all employees:According to the related provisions on national holidays &

FluoroPharm will exhibit CPhI North America 2020 in Pennsylvania Convention Center,Philadelphia, PA,

The U.S. Food and Drug Administration today granted accelerated approval to Rozlytrek (entrectinib),

According to the American Chemical and Engineering News (C&EN), the American Chemical Abstracts